Catalyst OrthoScience Announces David Sharp as Vice President of Global Marketing

April 12, 2022

NAPLES, Fla.–(BUSINESS WIRE)–Catalyst OrthoScience, a medical device company focused on the upper extremity orthopedics market, is pleased to announce that David Sharp has joined Catalyst as Vice President of Global Marketing effective immediately.

“We are excited to have an executive with David’s experience join our team at Catalyst OrthoScience,” said Catalyst OrthoScience CEO and President Carl O’Connell. “As we continue to grow and establish our presence as an emerging global leader in shoulder pathology solutions, David’s leadership and experience will help make that vision a reality.”

“I am excited to join the Catalyst team and contribute to the company’s goals that focus on sustainable growth and delivering real solutions to clinical unmet needs for shoulder surgeons and their patients around the world,” Sharp said. “I will be focused on growing a best-in-class marketing team and brand as we continue to build our core foundations in sales, marketing, R&D, and MedEd.”

Sharp brings more than 27 years of marketing, strategy, business development, communications and branding experience in the medical device industry, including roles with Sofamor Danek, Smith & Nephew, Medtronic Spinal & Biologics, Baxter International and most recently, MicroPort Orthopedics.

Sharp received a Bachelor of Science in Business Administration from the University of Memphis and a Master’s in International Business from Christian Brothers University.

About Catalyst OrthoScience Inc.

Catalyst OrthoScience is disrupting the usual approaches to shoulder replacement surgery. The Archer™ CSR Total Shoulder System is unique, offering precision and accuracy in shoulder restoration while preserving the patient’s bone and soft tissue. The Archer™ R1 Reverse Shoulder System is a single-tray arthroplasty system that offers surgeon-targeted implant positioning, a streamlined and versatile system, and bone sparing implants. Catalyst OrthoScience’s goal is to develop innovative medical solutions that make orthopedic surgery less invasive and more efficient for both surgeons and patients.

The company has a growing portfolio of patents and pending patents on its distinctive surgical offerings. Headquartered in Naples, Fla., Catalyst products are available across the U.S. For more information, visit www.CatalystOrtho.com.


Carl O’Connell
CEO and President
Catalyst OrthoScience

Chris J. Stewart

Chris currently serves as President and CEO of Surgio Health. Chris has close to 20 years of healthcare management experience, with an infinity to improve healthcare delivery through the development and implementation of innovative solutions that result in improved efficiencies, reduction of unnecessary financial & clinical variation, and help achieve better patient outcomes. Previously, Chris was assistant vice president and business unit leader for HPG/HCA. He has presented at numerous healthcare forums on topics that include disruptive innovation, physician engagement, shifting reimbursement models, cost per clinical episode and the future of supply chain delivery.

Related Articles

Back to top button